Suppr超能文献

相似文献

1
Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages.
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3012-7. doi: 10.1073/pnas.0914902107. Epub 2010 Jan 26.
2
A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.
J Immunol. 2011 Apr 15;186(8):4994-5003. doi: 10.4049/jimmunol.1003010. Epub 2011 Mar 16.
3
Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.
J Autoimmun. 2015 Feb;57:42-52. doi: 10.1016/j.jaut.2014.11.007. Epub 2014 Dec 29.
5
Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice.
Clin Immunol. 2016 Jan;162:31-6. doi: 10.1016/j.clim.2015.10.009. Epub 2015 Nov 10.
6
Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.
J Immunol. 2008 Feb 1;180(3):1938-47. doi: 10.4049/jimmunol.180.3.1938.
8
The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
J Immunol. 2017 Aug 15;199(4):1238-1249. doi: 10.4049/jimmunol.1700608. Epub 2017 Jul 10.

引用本文的文献

1
The Interplay of Cross-Organ Immune Regulation in Inflammation and Cancer.
MedComm (2020). 2025 Jun 15;6(7):e70249. doi: 10.1002/mco2.70249. eCollection 2025 Jul.
2
Immunometabolism in systemic lupus erythematosus.
Nat Rev Rheumatol. 2025 Jun 16. doi: 10.1038/s41584-025-01267-0.
3
Determining IFI44 as a key lupus nephritis's biomarker through bioinformatics and immunohistochemistry.
Ren Fail. 2025 Dec;47(1):2479575. doi: 10.1080/0886022X.2025.2479575. Epub 2025 Mar 18.
5
Human PBMC-based humanized mice exhibit myositis features and serve as a drug evaluation model.
Inflamm Regen. 2025 Jan 15;45(1):1. doi: 10.1186/s41232-025-00365-6.
7
Molecular Differences in Glomerular Compartment to Distinguish Immunoglobulin A Nephropathy and Lupus Nephritis.
J Inflamm Res. 2024 Dec 21;17:11357-11373. doi: 10.2147/JIR.S496138. eCollection 2024.
8
Interferon-α as a biomarker to predict renal outcomes in lupus nephritis.
Lupus Sci Med. 2024 Nov 28;11(2):e001347. doi: 10.1136/lupus-2024-001347.
10
Amplification of autoimmune organ damage by NKp46-activated ILC1s.
Nature. 2024 Oct;634(8035):952-960. doi: 10.1038/s41586-024-07907-x. Epub 2024 Aug 13.

本文引用的文献

1
Type I interferons produced by resident renal cells may promote end-organ disease in autoantibody-mediated glomerulonephritis.
J Immunol. 2009 Nov 15;183(10):6831-8. doi: 10.4049/jimmunol.0900742. Epub 2009 Oct 28.
2
IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation.
J Immunol. 2009 Nov 15;183(10):6469-77. doi: 10.4049/jimmunol.0901575. Epub 2009 Oct 19.
3
Clinical usefulness of a prognostic score in histological analysis of renal biopsy in patients with lupus nephritis.
J Rheumatol. 2009 Oct;36(10):2218-23. doi: 10.3899/jrheum.080793. Epub 2009 Jul 31.
4
Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies.
Blood. 2009 Aug 20;114(8):1675-83. doi: 10.1182/blood-2009-01-199117. Epub 2009 Jun 17.
7
Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.
Arthritis Res Ther. 2008;10(6):229. doi: 10.1186/ar2532. Epub 2008 Dec 1.
8
Exploring the full spectrum of macrophage activation.
Nat Rev Immunol. 2008 Dec;8(12):958-69. doi: 10.1038/nri2448.
10
Increased glomerular matrix metalloproteinase activity in murine lupus nephritis.
Kidney Int. 2008 Nov;74(9):1150-8. doi: 10.1038/ki.2008.308. Epub 2008 Jul 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验